Latest From Brainlab AG
At NANS, Boston Scientific presented results of the COMBO study, announced a partnership with IBM Research on digital health, and reported strong US growth in its deep brain stimulation business. Boston's C suite sees rebound for lagging neuromodulation business in 2020.
Nominee for US FDA commissioner has remained largely focused on academic work and private practice, receiving only a few payments from pharma and device companies.
Robotic systems took center stage at this year's annual spine society meeting in Chicago. NuVasive unveiled its new Pulse robotic spine surgery system with several differentiating features. Globus Medical showcased a new imaging platform and Interbody module.
The orthopedics giant will pay $27.50 per share for the Leesburg, Va., company, representing a 27% premium over K2M's average closing price over the last 90 days. The terms of the deal also call for K2M CEO to take over as president of Stryker's Spine business, displacing current president Bradley Paddock.
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- MRI, NMR
Surgical Equipment & Devices
- Minimally or Less Invasive
- Diagnostic Imaging Equipment & Supplies
- Therapeutic Areas
- Musculoskeletal & Connective Tissue Disorders
- Neurology, Nervous System
- BrainLAB AG
- Western Europe
- Parent & Subsidiaries
- Brainlab AG
- Senior Management
Stefan Vilsmeier, CEO
Joseph Doyle, CFO
- Contact Info
Phone: (49) 89 99 15680
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.